Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.Newsfile Corp • 05/03/21
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.PRNewsWire • 05/01/21
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline - EBSNewsfile Corp • 05/01/21
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: BloombergBenzinga • 04/30/21
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)Newsfile Corp • 04/30/21
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within DaysBenzinga • 04/30/21
EMERGENT INVESTORS: June 18, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 04/30/21
Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/30/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBSPRNewsWire • 04/30/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Class Action Filed, Application Deadline EstablishedNewsfile Corp • 04/29/21
EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 04/29/21
EBS Stock: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 04/28/21
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. - EBSNewsfile Corp • 04/27/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO's Insider SalesPRNewsWire • 04/27/21
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Emergent BioSolutions Inc.'s Directors and Officers for Breach of Fiduciary Duties – EBSBusiness Wire • 04/27/21
CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson dosesFox Business • 04/26/21
A vaccine maker ruined 15 million doses. Its CEO sold $11 million of stock before that was publicCNN Business • 04/26/21